EMBL-EBI | Chemical Biology Resources | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:749553 - daclizumab
| ChEBI ID | CHEBI:749553 |
| ChEBI Name | daclizumab |
| Stars | |
| Last Modified | 29 June 2026 |
| Submitter | ChEMBL |
| Roles Classification |
|---|
| Biological Roles: | anti-HIV agent An antiviral agent that destroys or inhibits the replication of the human immunodeficiency virus. immunosuppressive agent An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response. |
| Applications: | anti-anaemic agent A compound which increases either the number of red cells or the amount of haemoglobin in the blood. antipsoriatic A drug used to treat psoriasis. hypoglycemic agent A drug which lowers the blood glucose level. immunosuppressive agent An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response. anti-asthmatic agent Any compound that has anti-asthmatic effects. anti-inflammatory agent Any compound that has anti-inflammatory effects. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. ophthalmology drug Any compound used for the treatment of eye conditions or eye diseases. renoprotective agent Any compound that is able to prevent damage to the kidneys. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| daclizumab (CHEBI:749553) has role anti-anaemic agent (CHEBI:75835) |
| daclizumab (CHEBI:749553) has role anti-asthmatic agent (CHEBI:65023) |
| daclizumab (CHEBI:749553) has role anti-HIV agent (CHEBI:64946) |
| daclizumab (CHEBI:749553) has role anti-inflammatory agent (CHEBI:67079) |
| daclizumab (CHEBI:749553) has role antineoplastic agent (CHEBI:35610) |
| daclizumab (CHEBI:749553) has role antipsoriatic (CHEBI:50748) |
| daclizumab (CHEBI:749553) has role hypoglycemic agent (CHEBI:35526) |
| daclizumab (CHEBI:749553) has role immunosuppressive agent (CHEBI:35705) |
| daclizumab (CHEBI:749553) has role ophthalmology drug (CHEBI:66981) |
| daclizumab (CHEBI:749553) has role renoprotective agent (CHEBI:231911) |
| daclizumab (CHEBI:749553) is a organic molecular entity (CHEBI:50860) |
| Synonyms | Source |
|---|---|
| Daclizumab | ChEMBL |
| Daclizumab beta | ChEMBL |
| RO 24-7375 | ChEMBL |
| RO-24-7375 | ChEMBL |
| Brand Names | Source |
|---|---|
| Zenapax | ChEMBL |
| Zinbryta | ChEMBL |